- Home
- FRAF vs EVMN Comparison
FRAF vs EVMN Comparison
Compare FRAF & EVMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FRAF | EVMN |
|---|---|---|
| Founded | 1906 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 279.0M | 241.3M |
| IPO Year | 1995 | 2025 |
Fundamental Metrics
Financial Performance| Metric | FRAF | EVMN |
|---|---|---|
| Price | $63.95 | $6.39 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 11 |
| Target Price | N/A | ★ $24.13 |
| AVG Volume (30 Days) | 25.4K | ★ 762.1K |
| Earning Date | 10-27-2026 | 11-07-2026 |
| Dividend Yield | ★ 2.15% | N/A |
| EPS Growth | ★ 88.84 | 75.23 |
| EPS | ★ 2.94 | N/A |
| Revenue | N/A | ★ $13,000,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $6.58 | N/A |
| P/E Ratio | $21.54 | ★ N/A |
| Revenue Growth | N/A | ★ 85.71 |
| 52 Week Low | $43.47 | $6.02 |
| 52 Week High | $65.41 | $33.20 |
Technical Indicators
Market Signals| Indicator | FRAF | EVMN |
|---|---|---|
| Relative Strength Index (RSI) | 53.99 | 19.23 |
| Support Level | $60.34 | N/A |
| Resistance Level | $64.44 | $13.35 |
| Average True Range (ATR) | 1.58 | 0.56 |
| MACD | 0.08 | -0.16 |
| Stochastic Oscillator | 81.28 | 8.84 |
Price Performance
Historical ComparisonAbout FRAF Franklin Financial Services Corporation
Franklin Financial Services Corp is a bank holding company based in the United States. It is engaged in general commercial, retail banking, and trust services normally associated with community banks. It offers a broad range of banking services to businesses, individuals, and governmental entities, which include accepting and maintaining cheques, savings, and time deposit accounts, providing investment and trust services, making loans and providing safe deposit facilities. The bank also performs personal, corporate, pension and fiduciary services through its Investment and Trust Services Department.
About EVMN Evommune Inc.
Evommune Inc is a clinical-stage biotechnology company focused on creating new therapies aimed at key factors driving chronic inflammatory diseases. The initial clinical programs of the company target chronic spontaneous urticaria (CSU), atopic dermatitis (AD), and ulcerative colitis (UC). The pipeline products of the company include EVO756 and EVO301.